Lin Caiyu - Department of Respiratory Disease Daping Hospital, Army Medical University

基本信息

浏览量：5

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 42 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

AXIN1/MYC Axis Mediated the Osimertinib Resistance in EGFR Mutant Non-Small Cell Lung Cancer Cells

Haoyue Yu, Zhiguo Wang,Yan Dong, Li,Xianming Fan, Nan Zheng, Ji Jiang,Caiyu Lin,Conghua Lu,Kunlin Li,Mingxia Feng

The Tohoku journal of experimental medicineno. 4 (2024): 269-276

引用0浏览0WOS引用

Overall Signature of Acquired KRAS Gene Changes in Advanced Non-Small Cell Lung Cancer Patient with EGFR-TKI Resistance

Jie Zheng,Yuanyao Dou,Daijuan Huang,Yubo Wang,Rui Han, Chen Hu,Mengxiao Zhu,Conghua Lu,Caiyu Lin,Di Wu, Yihui Liu,Huan Tang,Tingting He, Weilin Jiang,Yong He

JAPANESE JOURNAL OF CLINICAL ONCOLOGY（2024）

引用0浏览0WOS引用

Metformin Promotes Anti-Tumor Immunity in STK11 Mutant NSCLC Through AXIN1-dependent Upregulation of Multiple Nucleotide Metabolites

Zhiguo Wang, Kunlin Li,Conghua Lu,Mingxia Feng,Caiyu Lin, Guofang Yin, Dan Luo, Wenyi Liu, Kaiyu Jin, Yuanyao Dou, D I Wu, Jie Zheng,Kejun Zhang, L I Li,Xianming Fan

Oncology researchno. 10 (2024): 1637-1648

引用0浏览0WOS引用

Understanding the Dynamics of TKI-induced Changes in the Tumor Immune Microenvironment for Improved Therapeutic Effect

Conghua Lu, Ziyuan Gao, Di Wu, Jie Zheng, Chen Hu,Daijuan Huang, Chao He, Yihui Liu,Caiyu Lin, Tao Peng,Yuanyao Dou, Yimin Zhang,Fenfen Sun, Weiling Jiang,Guoqing Yin,Rui Han,Yong He

JOURNAL FOR IMMUNOTHERAPY OF CANCERno. 6 (2024)

引用0浏览0WOS引用

Brigatinib, a Newly Discovered AXL Inhibitor, Suppresses AXL-mediated Acquired Resistance to Osimertinib in EGFR-mutated Non-Small Cell Lung Cancer

Rui Han,Cong-hua Lu, Chen Hu,Yuan-yao Dou,Jun Kang,Cai-yu Lin,Di Wu, Wei-ling Jiang,Guo-qing Yin,Yong He

Acta Pharmacologica Sinicapp.1-12, (2024)

引用0浏览0WOSNATURE引用

Sialyltransferase ST3GAL4 Confers Osimertinib Resistance and Offers Strategies to Overcome Resistance in Non-Small Cell Lung Cancer

Rui Han,Caiyu Lin,Conghua Lu,Yubo Wang,Jun Kang,Chen Hu,Yuanyao Dou,Di Wu,TingTing He,Huan Tang, Jie Zheng, Li,Yong He

Cancer letterspp.216762-216762, (2024)

引用0浏览0WOS引用

Mesoporous Manganese Nanocarrier Target Delivery Metformin for the Co-Activation STING Pathway to Overcome Immunotherapy Resistance

Yuanyao Dou,Jie Zheng,Jun Kang, Liping Wang,Daijuan Huang, Yihui Liu, Chao He,Caiyu Lin,Conghua Lu,Di Wu,Rui Han, Li,Liling Tang,Yong He

ISCIENCEno. 7 (2024)

引用0浏览0WOS引用

The Potential Therapeutic Regimen for Overcoming Resistance to Osimertinib Due to Rare Mutations in NSCLC

Rui Han,Caiyu Lin,Chong Zhang,Jun Kang,Conghua Lu, Yiming Zhang,Yubo Wang, Chen Hu,Yong He

iScienceno. 7 (2023): 107105-107105

引用0浏览0WOS引用

Ph-Responsive Theranostic Nanoplatform of Ferrite and Ceria Co-Engineered Nanoparticles for Anti-Inflammatory

Yuanyao Dou, Yimin Zhang,Caiyu Lin,Rui Han,Yubo Wang,Di Wu,Jie Zheng,Conghua Lu,Liling Tang,Yong He

Frontiers in bioengineering and biotechnology（2022）

引用3浏览0WOS引用

Metformin Combining PD-1 Inhibitor Enhanced Anti-Tumor Efficacy in STK11 Mutant Lung Cancer Through AXIN-1-Dependent Inhibition of STING Ubiquitination

Zhiguo Wang,Conghua Lu,Kejun Zhang,Caiyu Lin,Fang Wu,Xiaolin Tang,Di Wu,Yuanyao Dou,Rui Han,Yubo Wang,Chao Hou,Qin Ouyang,Mingxia Feng,Yong He, Li Li

FRONTIERS IN MOLECULAR BIOSCIENCES（2022）

引用5浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn